RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

188 hedge funds and large institutions have $411M invested in Revance Therapeutics, Inc. in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 41 closing their positions.

Holders
188
Holders Change
-5
Holders Change %
-2.59%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
60
Reduced
54
Closed
41
Calls
$4.96M
Puts
$2.92M
Net Calls
+$2.04M
Net Calls Change
-$10.7M
Name Holding Trade Value Shares
Change
Shares
Change %
BAM
226
Bellevue Asset Management
Washington
-$1.21K -138 Closed
VCM
227
Versant Capital Management
Arizona
-$545 -62 Closed